Magnolol attenuates VCAM-1 expressionin vitroin TNF-α-treated human aortic endothelial cells andin vivoin the aorta of cholesterol-fed rabbits
Open Access
- 29 January 2002
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 135 (1) , 37-47
- https://doi.org/10.1038/sj.bjp.0704458
Abstract
In a previous study, we showed that magnolol, a potent antioxidant derived from a Chinese herb, attenuates monocyte chemotactic protein-1 (MCP-1) expression and intimal hyperplasia in the balloon-injured aorta of cholesterol-fed rabbits. Expression of cell adhesion molecules by the arterial endothelium and the attachment of leukocytes to the endothelium may play a major role in atherosclerosis. In the present study, the effects of magnolol on the expression of endothelial-leukocyte adhesion molecules and the activation of nuclear factor kappa B (NF-κB) in tumour necrosis factor-α (TNF-α)-treated human aortic endothelial cells (HAECs) were investigated. Pretreatment of HAECs with magnolol (5 μM) significantly suppressed the TNF-α-induced expression of vascular cell adhesion molecule-1 (VCAM-1) (64.8±1.9%), but had no effect on the expression of intercellular cell adhesion molecule-1 and endothelial cell selectin. Magnolol (5 and 10 μM) significantly reduced the binding of the human monocytic cell line, U937, to TNF-α-stimulated HAECs (58.4 and 56.4% inhibition, respectively). Gel shift assays using the 32P-labelled NF-κB consensus sequence as probe showed that magnolol pretreatment reduced the density of the shifted bands seen after TNF-α-induced activation. Immunoblot analysis and immunofluorescence staining of nuclear extracts demonstrated a 58% reduction in the amount of NF-κB p65 in the nuclei in magnolol-treated HAECs. Magnolol also attenuated intracellular H2O2 generation in both control and TNF-α treated HAECs. Furthermore, in vivo, magnolol attenuates the intimal thickening and TNF-α and VCAM-1 protein expression seen in the thoracic aortas of cholesterol-fed rabbits. Taken together, these data demonstrate that magnolol inhibits TNF-α-induced nuclear translocation of NF-κB p65 and thereby suppresses expression of VCAM-1, resulting in reduced adhesion of leukocytes. These results suggest that magnolol has anti-inflammatory properties and may play important roles in the prevention of atherosclerosis and inflammatory responses in vivo. British Journal of Pharmacology (2002) 135, 37–47; doi:10.1038/sj.bjp.0704458Keywords
This publication has 39 references indexed in Scilit:
- Magnolol stimulates steroidogenesis in rat adrenal cellsBritish Journal of Pharmacology, 2000
- The in vitro antioxid ant activity of trilinolein and other lipid-related natural substances as measured by enhanced chemiluminescenceLife Sciences, 1996
- Probucol Downregulates E-Selectin Expression on Cultured Human Vascular Endothelial CellsArteriosclerosis, Thrombosis, and Vascular Biology, 1996
- Magnolol Protects Human Sperm Motility Against Lipid Peroxidation: A Sperm Head Fixation MethodArchives of Andrology, 1995
- A primary culture system of adult rat heart cells for the evaluation of cocaine toxicityToxicology, 1992
- Antihaemostatic and antithrombotic effect of some antiplatelet agents isolated from Chinese herbsJournal of Pharmacy and Pharmacology, 1991
- Endothelial Expression of a Mononuclear Leukocyte Adhesion Molecule During AtherogenesisScience, 1991
- Activation in vitro of NF-κB" by phosphorylation of its inhibitor IκB"Nature, 1990
- EDRF-release and Ca++-channel blockade by magnolol, an antiplatelet agent isolated from Chinese herb ,in rat thoracic aortaLife Sciences, 1989
- Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1984